1. Monagle P, Adams M, Mahoney M, et al. Outcome
of pediatric thromboembolic disease: a report from the Canadian
Childhood Thrombophilia Registry.
Pediatr Res. 2000;47:763-766.
[PubMed: 10832734]
2. Schmidt B, Andrew M. Neonatal thrombosis: report of a prospective
Canadian and international registry.
Pediatrics. 1995;96:939-943.
[PubMed: 7478839]
3. Richardson MW, Allen GA, Monahan PE. Thrombosis in children:
current perspective and distinct challenges.
Thromb Haemost. 2002;88:900-911.
[PubMed: 12529737]
4. Kurnik K, Duering C, Bidlingmaier C, Nowak-Gottl U. Thromboembolism
in neonates and infants: impact of underlying diseases, prothrombotic
risk factors and treatment modalities. Thromb Res. 2005;115(suppl
1):71-77.
5. Kuhle S, Massicotte P, Chan A, et al. Systemic
thromboembolism in children. Data from the 1-800-NO-CLOTS Consultation
Service.
Thromb Haemost. 2004;92:722-728.
[PubMed: 15467901]
6. Heller C, Heinecke A, Junker R, et al. Cerebral venous thrombosis in
children: a multifactorial origin.
Circulation. 2003;108:1362-1367.
[PubMed: 12939214]
7. Journeycake JM, Buchanan GR. Thrombotic complications of
central venous catheters in children.
Curr Opin Hematol. 2003;10:369-374.
[PubMed: 12913792]
8. Massicotte MP, Dix D, Monagle P, Adams M, Andrew M. Central venous
catheter related thrombosis in children: analysis of the Canadian
Registry of Venous Thromboembolic Complications.
J Pediatr. 1998;133:770-776.
[PubMed: 9842042]
9. Nowak-Gottl U, Duering C, Kempf-Bielack B, Strater R. Thromboembolic
diseases in neonates and children.
Pathophysiol Haemost
Thromb. 2003;33:269-274.
[PubMed: 15692228]
10. Nowak-Gottl U, Junker R, Kreuz W, et al. Risk of recurrent venous
thrombosis in children with combined prothrombotic risk factors.
Blood. 2001;97:858-862.
[PubMed: 11159508]
11. Male C, Chait P, Ginsberg JS, et al. Comparison of venography and
ultrasound for the diagnosis of asymptomatic deep vein thrombosis
in the upper body in children: results of the PARKAA study. Prophylactic
Antithrombin Replacement in Kids with ALL treated with Asparaginase.
Thromb
Haemost. 2002;87:593-598.
[PubMed: 12008940]
12. Kaste SC, Gronemeyer SA, Hoffer FA, Mandrell BN, Wilimas JA.
Pilot study of noninvasive detection of venous occlusions from central
venous access devices in children treated for acute lymphoblastic
leukemia.
Pediatr Radiol. 1999;29:570-574.
[PubMed: 10415178]
13. Baarslag HJ, Van Beek EJ, Reekers JA. Magnetic resonance venography
in consecutive patients with suspected deep vein thrombosis of the
upper extremity: initial experience.
Acta Radiol. 2004;45:38-43.
[PubMed: 15164777]
14. Lordick F, Hentrich M, Decker T, et al. Ultrasound screening
for internal jugular vein thrombosis aids the detection of central venous
catheter-related infections in patients with haemato-oncological
diseases: a prospective observational study.
Br J Haematol. 2003;120:1073-1078.
[PubMed: 12648081]
15. Sevestre MA, Kalka C, Irwin WT, Ahari HK, Schainfeld RM. Paget-Schroetter
syndrome: what to do?
Catheter Cardiovasc Interv. 2003;59:71-76.
[PubMed: 12720245]
16. Angle N, Gelabert HA, Farooq MM, et al. Safety and efficacy
of early surgical decompression of the thoracic outlet for Paget-Schroetter
syndrome.
Ann Vasc Surg. 2001;15:37-42.
[PubMed: 11221942]
17. Feugier P, Aleksic I, Salari R, Durand X, Chevalier JM.
Long-term results of venous revascularization for Paget-Schroetter
syndrome in athletes.
Ann Vasc Surg. 2001;15:212-218.
[PubMed: 11265086]
18. Kreienberg PB, Chang BB, Darling RC 3rd, et al. Long-term results
in patients treated with thrombolysis, thoracic inlet decompression,
and subclavian vein stenting for Paget-Schroetter syndrome. J
Vasc Surg. 2001;33(2 suppl):S100-S105.
19. May R, Thurner J. The cause of predominately sinistral occurrence
of thrombosis of the pelvic veins.
Angiology. 1957;8:419-427.
[PubMed: 13478912]
20. Kibbe M, Ujiki M, Goodwin A Lee, et al. Iliac vein compression in
an asymptomatic patient population.
J Vasc Surg. 2004;
39:937-943.
[PubMed: 15111841]
21. Raffini L, Raybagkar D, Cahill AM, Kaye R, Blumenstein M,
Manno C. May-Thurner syndrome (iliac vein compression) and thrombosis in
adolescents.
Pediatr Blood Cancer. 2006;47:834-838.
[PubMed: 16365865]
22. Biss TT, Brandão LR, Kahr WH, Chan AK, Williams
S. Clinical features and outcome of pulmonary embolism in children. Br
J Haematol. 2008;142(5):808-818.
23. Manco-Johnson MJ, Nuss R. Lupus anticoagulant in children with
thrombosis.
Am J Hematol. 1995;48:240-243.
[PubMed: 7717372]
24. Nuss R, Hays T, Chudgar U, and Manco-Johnson M. Antiphospholipid
antibodies and coagulation regulatory protein abnormalities in children
with pulmonary emboli.
J Pediatr Hematol/Oncol. 1997;19:
202-207.
[PubMed: 9201141]
25. Xiang DZ,Verbeken EW, Lommel V, and De Wever I. Sleeve-related
thrombosis: a new form of catheter-related thrombosis.
Thromb
Res. 2001;104:7-14.
[PubMed: 11583734]
26. Tolar B, Gould JR. The timing and sequence of multiple device-related
complications in patients with long term indwelling Groshong catheters.
Cancer. 1996;78:1308-1313.
[PubMed: 8826955]
27. Choi M., Massicotte MP, Marzinotto V, Chan AKC, Holmes JL
and Andrew M. The use of alteplase to restore patency of central
venous lines in pediatric patients: a cohort study.
J Pediatr. 2001;139:152-156.
[PubMed: 11445811]
28. Timoney JP, Malkin DM, Leane JS, et al. Safe and cost effective
use of alteplase for the clearance of occluded central venous access
devices.
J Clin Oncol. 2002;20:1918-1922.
[PubMed: 11919252]
29. Male C, Chait P, Andrew M, Hanna K, Julian J, and Mitchell
L. Central venous line-related thrombosis in children: association
with central venous line location and insertion technique.
Blood. 2003;101:4273-4278.
[PubMed: 12560228]
30. Journeycake JM, Quinn CT, Miller KL, Zajac JL, Buchanan GR.
Catheter-related deep venous thrombosis in children with hemophilia.
Blood. 2001;98:1727-1731.
[PubMed: 11535504]
31. Glaser D, Medeiros D, Rollins N, and Buchanan GR. Catheter-related
thrombosis in children with cancer.
J Pediatr. 2001;138:255-259.
[PubMed: 11174625]
32. Andrew M, Marzinotto V, Pencharz P, Zlotkin S, et al. A cross-sectional
study of catheter-related thrombosis in children receiving total
parenteral nutrition at home.
J Pediatr. 1995;126:358-363.
[PubMed: 7869192]
33. Price VE, Carcao M, Connolly B, et al. A prospective, longitudinal
study of central venous catheter-related deep venous thrombosis
in boys with hemophilia.
J Thromb Haemost. 2004;2:737-742.
[PubMed: 15099279]
34. Hanna H, Benjamin R, Chatzinikolaou I, et al. Long-term
silicone central venous catheters impregnated with
minocycline and
rifampin decrease rates of catheter-related bloodstream infection
in cancer patients: a prospective randomized clinical trial.
J
Clin Oncol. 2004;22:3163-3171.
[PubMed: 15284269]
35. Enrickson KJ, Axtell RA, Hoover SM, et al. Prevention of
central venous catheter-related infections and thrombotic events
in immunocompromised children by the use of
vancomycin/
ciprofloxacin/heparin
flush solution: randomized, multicenter, double-blind trial.
J
Clin Oncol. 2000;18:1269-1278.
36. Dillon PW, Jones GR, Bagnall-Reeb HA, Buckley JD, Wiener
ES, Haase GM. Prophylactic urokinase in the management of long-term venous
access devices in children: A Children’s Oncology Group
study.
J Clin Oncol. 2004;22:2718-2723.
[PubMed: 15226339]
37. Pierce CM, Wade A, Mok Q. Heparin-bonded central venous lines
reduce thrombotic and infective complications in critically ill children.
Intensive
Care Med. 2000;26:967-972.
[PubMed: 10990114]
38. van Rooden CJ, Schippers EF, Barge RMY, et al. Infectious
complications of central venous catheters increase the risk of catheter-related
thrombosis in hematology patients: a prospective study. J
Clin Oncol. 2005;23:2655-2660.
39. Journeycake JM, Buchanan GR. Catheter-related deep vein thrombosis
and other catheter complications in children with cancer.
J
Clin Oncol. 2006;24:4575-4580.
[PubMed: 17008698]
40. Bona RD. Thrombotic complications of central venous catheters in
cancer patients.
Semin Thromb Hemost. 1999;25:147-155.
[PubMed: 10357082]
41. Mehall JR, Saltzman DA, Jackson RJ, Smith SD. Fibrin sheath
enhances central venous catheter infection.
Crit Care Med. 2002;30:908-912.
[PubMed: 11940768]
42. Puel V, Caudry M, Le Metayer P, et al. Superior vena cava
thrombosis related to catheter malposition in cancer chemotherapy
given through implanted ports.
Cancer. 1993;72:2248-2252.
[PubMed: 8374884]
43. Wacker P, Oberhansli I, Didier D, et al. Right atrial thrombosis
associated with central venous catheters in children with cancer.
Med
Pediatr Oncol. 1994;22:53-57.
[PubMed: 8232081]
44. Kowalski CM, Kaufman JA, Rivitz SM, Geller SC, Waltman AC.
Migration of central venous catheters: implications for initial catheter
tip positioning.
J Vasc Interv Radiol. 1997;8:443-447.
[PubMed: 9152919]
45. Fuchs S, Pollak A, Gilon D. Central venous catheter mechanical
irritation of the right atrial free wall: a cause for thrombus formation.
Cardiology. 1999;91:169-172.
[PubMed: 10516410]
46. Mokrohisky ST, Levine RS, Blumhagen JD, Wesenberg RL. Low
positioning of umbilical-artery catheters increases associated complications
in newborn infants.
N Engl J Med. 1978;299:561-564.
[PubMed: 683224]
47. Bambauer R, Inniger R, Pirrung KJ, Pirrung KJ, Schiel R, Dahlem
R. Complications and side effects associated with large-bore catheters
in the subclavian and internal jugular veins.
Artif Organs. 1994;18:318-321.
[PubMed: 8024484]
48. Male C, Chait P, Andrew M, Hanna K, Julian J, Mitchell L. Central
venous line-related thrombosis in children: association with central
venous line location and insertion technique.
Blood. 2003;101:4273-4278.
[PubMed: 12560228]
49. Monagle P, Chalmers E, Chan A, et al. Antithrombotic therapy
in infants and children: American College of Chest Physicians evidence-based
clinical practice guidelines. Chest. 2008;133(6
suppl):887S-968S.
50. Lynch JK, Hirtz DG, DeVeber G, Nelson KB. Report of the
National Institute of Neurological Disorders and Stroke workshop
on perinatal and childhood stroke.
Pediatrics. 2002;109:116-123.
[PubMed: 11773550]
51. deVeber G, Andrew M, Adams C, et al. Cerebral sinovenous thrombosis
in children.
N Engl J Med. 2001;345:417-423.
[PubMed: 11496852]
52. deVeber G, Monagle P, Chan A, et al. Prothrombotic disorders in
infants and children with cerebral thromboembolism.
Arch
Neurol. 1998; 55:1539-1543.
[PubMed: 9865798]
53. Buller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob
GE. Antithrombotic therapy for venous thromboembolic disease: the
Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3
suppl):401S-428S.
54. deVeber G, Chan A, Monagle P, et al. Anticoagulation therapy
in pediatric patients with sinovenous thrombosis: a cohort study.
Arch
Neurol. 1998;55:1533-1537.
[PubMed: 9865797]
55. Andrew ME, Monagle P, deVeber G, Chan AK. Thromboembolic
disease and antithrombotic therapy in newborns. Hematology
(Am Soc Hematol Educ Program). 2001:358-374.
56. Nowak-Gottl U, Kosch A, Schlegel N. Neonatal thromboembolism.
Semin
Thromb Hemost. 2003;29:227-234.
[PubMed: 12709927]
57. Golomb MR, Fullerton HJ, Nowak-Gottl U, Deveber G. Male predominance
in childhood ischemic stroke. findings from the International Pediatric
Stroke Study.
Stroke. 2009;40:52-57.
[PubMed: 18787197]
58. Ozduman K, Pober BR, Barnes P, et al. Fetal stroke.
Pediatr
Neurol. 2004;30:151-162.
[PubMed: 15033196]
59. Counsell SJ, Rutherford MA, Cowan FM, Edwards AD. Magnetic
resonance imaging of preterm brain injury. Arch Dis Child
Fetal Neonatal Ed. 2003;88:F269-F274.
60. Golomb MR, Dick PT, MacGregor DL, Armstrong DC, DeVeber
GA. Cranial ultrasonography has a low sensitivity for detecting
arterial ischemic stroke in term neonates.
J Child Neurol. 2003;18:98-103.
[PubMed: 12693775]
61. deVeber G. Arterial ischemic strokes in infants and children:
an overview of current approaches.
Semin Thromb Hemost. 2003;29:567-573.
[PubMed: 14719173]
62. Golomb MR, MacGregor DL, Domi T, et al. Presumed pre- or perinatal
arterial ischemic stroke: risk factors and outcomes.
Ann
Neurol. 2001;50:163-168.
[PubMed: 11506398]
63. Lynch JK, Hirtz DG, DeVeber G, Nelson KB. Report of the
National Institute of Neurological Disorders and Stroke workshop
on perinatal and childhood stroke.
Pediatrics. 2002;109:116-123.
[PubMed: 11773550]
64. Brankovic-Sreckovic V, Milic-Rasic V, Jovic N, Milic N, Todorovic
S. The recurrence risk of ischemic stroke in childhood. Med
Princ Pract. 2004;13(3):153-158.
65. Golomb MR, deVeber GA, MacGregor DL, et al. Independent walking
after neonatal arterial ischemic stroke and sinovenous thrombosis. J
Child Neurol. 2003;18(8):530-536.
66. DeVeber G. Risk factors for childhood stroke: little folks
have different strokes! Ann Neurol. 2003;53(2):149-150.
67. Wirrell E, Hill MD, Jadavji T, Kirton A, Barlow K. Stroke
after varicella vaccination. J Pediatr. 2004;145(6):845-847.
68. Saxena K, Ranalli M, Khan N, Blanchong C, Kahwash SB. Fatal stroke
in a child with severe iron deficiency anemia and multiple hereditary
risk factors for thrombosis. Clin Pediatr (Phila). 2005;44(2):175-180.
69. deVeber G, Chan A. Aspirin versus low-molecular-weight heparin
for ischemic stroke in children: an unanswered question.
Stroke. 2002;
33:1947-1948, author reply 1947-1948.
[PubMed: 12154242]
70. Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P. Antithrombotic
and thrombolytic therapy for ischemic stroke: American College of
Chest Physicians Evidence-Based Clinical Practice Guidelines (8th
Ed). Chest 2008;133(6 Suppl):630S-669S.
71. Lau KK, Stoffman JM, Williams S, et al. Neonatal renal vein thrombosis:
review of the English-language literature between 1992 and 2006. Pediatr. 2007;120:e1278-e1284.
72. Singhal R, Brimble KS. Thromboembolic complications in the
nephrotic syndrome: pathophysiology and clinical management.
Thromb
Res. 2006;118:397-407.
[PubMed: 15990160]
73. Schettino GC, Fagundes ED, Roquete ML, Ferreira AR, Penna FJ.
Portal vein thrombosis in children and adolescents.
J Pediatr
(Rio J). 2006;82:171-178.
[PubMed: 16773174]
74. Mathew P, Manco-Johnson M, Hutter JJ, et al. Early clot
recurrence or progression is not increased in children with genetic thrombophilia—preliminary
results from the Regional Thrombophilia Registry Eight and Ten (the ReTREAT
Study). Blood. 2003;102:548a.
75. Tormene D, Simioni P, Prandoni P, et al. The incidence of venous
thromboembolism in thrombophilic children: a prospective cohort
study.
Blood. 2002;100:2403-2405.
[PubMed: 12239149]
76. Middeldorp S, Meinardi JR, Koopman MMW, et al. A prospective
study of asymptomatic carriers of the factor V Leiden mutation to
determine the incidence of venous thromboembolism.
Ann Intern
Med. 2001;135:322-327.
[PubMed: 11529695]
77. Young G, Albisetti M, Bonduel M, et al. Impact of inherited thrombophilia
on venous thromboembolism in children: a systematic review and meta-analysis
of observational studies.
Circulation. 2008;118:1373-1382.
[PubMed: 18779442]
78. Egeberg O. Thrombophilia caused by inheritable deficiency
of blood antithrombin.
Scand J Clin Lab Invest. 1965;17:92.
[PubMed: 14260761]
79. Griffin JH, Evatt B, Zimmerman TS, et al. Deficiency of
protein C in congenital thrombotic disease.
J Clin Invest. 1981;68:1370-1373.
[PubMed: 6895379]
80. Schwarz HP, Fischer M, Hopmeier P, Batard MA, Griffin JH.
Plasma protein S deficiency in familial thrombotic disease.
Blood. 1984;64:1297-1300.
[PubMed: 6238642]
81. Marlar RA, Montgomery RR, Broekmans AW, et al. Diagnosis
and treatment of homozygous protein C deficiency.
J Pediatr. 1989;114:528-534.
[PubMed: 2647943]
82. Dreyfus M, Masterson M, David M, et al. Replacement therapy
with a monoclonal antibody purified protein C concentrate in newborns with
severe congenital protein C deficiency.
Semin Thromb Hemost. 1995;21:371-381.
[PubMed: 8747700]
83. Manco-Johnson MJ, Nuss R. Thrombophilia in the infant and
child.
Adv Pediatr. 2001;48:363-384.
[PubMed: 11480763]
84. Andrew M. Developmental hemostasis: relevance to hemostatic problems
during childhood.
Semin Thromb Hemost. 1995;21:341-354.
[PubMed: 8747697]
85. Mitchell LG, Sutor AH, Andrew M. Hemostasis in childhood acute
lymphoblastic leukemia: coagulopathy induced by disease and treatment.
Semin
Thromb Hemost. 1995;21:390-400.
[PubMed: 8747702]
86. Nowak-Gottl U, Dubbers A, Kececioglu D, et al. Factor V
Leiden, protein C, and lipoprotein (a) in catheter-related thrombosis
in childhood: a prospective study.
J Pediatr. 1997;131:
608-612.
[PubMed: 9386668]
87. Bauer KA. The thrombophilias: well-defined risk factors
with uncertain therapeutic implications.
Ann Intern Med. 2001;135:367-373.
[PubMed: 11529700]
88. Koster R, Blann AD, Briet E, Vandenbroucke JP, Rosendaal
FR. Role of clotting factor VIII in effect of von Willebrand factor
on occurrence of deep-vein thrombosis.
Lance. 1995;345:152-155.
[PubMed: 7823669]
89. van Hylckama Vlieg A, van der Linder IK, Bertina RM, Rosendaal
FR. High levels of factor IX increase the risk of venous thrombosis. Blood. 2000;95:3678-3682.
90. Meijers JC, Tekelenburg WL, Bouma BN, Bertina RM, Rosendaal
FR. High levels of coagulation factor XI as a risk factor for venous
thrombosis.
N Engl J Med. 2000;342:696-701.
[PubMed: 10706899]
91. Lane DA, Grant PJ. Role of hemostatic gene polymorphisms
in venous and arterial thrombotic disease.
Blood. 2000;95:1517-1532.
[PubMed: 10688804]
92. Goldenberg NA, Knapp-Clevenger R, Manco-Johnson MJ. Elevated
plasma factor VIII and D-dimer levels as predictors of poor outcomes
of thrombosis in children.
N Engl J Med. 2004;351:1081-1088.
[PubMed: 15356305]
93. Athale UH, Chan AK. Thrombosis in children with acute lymphoblastic
leukemia. Pathogenesis of thrombosis in children with acute lymphoblastic
leukemia: effects of the disease and therapy. Thromb Res. 2003;111(4-5,
Pt 2):199-212.
94. Schmid L, Walser K, Kessler W, Senn HJ. Use of a fully implantable
drug delivery system in the treatment of acute leukemias and disseminated lymphomas. Oncology. 1990;47(6):449-455.
95. Athale UH, Chan AK. Thrombosis in children with acute lymphoblastic
leukemia. Pathogenesis of thrombosis in children with acute lymphoblastic
leukemia: effects of host environment. Thromb Res. 2003;111(6
Pt 2):321-327.
96. Nowak-Gottl U, Heinecke A, von Kries R, Nurnberger W, Munchow
N, Junker R. Thrombotic events revisited in children with acute
lymphoblastic leukemia: impact of concomitant
Escherichia
coli asparaginase/prednisone administration.
Thromb
Res. 2001;103: 165-172.
[PubMed: 11672578]
97. Mitchell L, Andrew M, Hanna K, et al. Trend to efficacy
and safety using antithrombin concentrate in prevention of thrombosis
in children receiving L-asparaginase for acute lymphoblastic leukemia.
Results of the PAARKA study. Thromb Haemost. 2003;90(2):235-244.
98. Nowak-Gottl U, Ahlke E, Fleischhack G, et al. Thromboembolic
events in children with acute lymphoblastic leukemia (BFM protocols):
prednisone versus
dexamethasone administration.
Blood. 2003;101:2529-2533.
[PubMed: 12517808]
99. Kieslich M, Porto L, Lanfermann H, Jacobi G, Schwabe D, Bohles
H. Cerebrovascular complications of L-asparaginase in the therapy
of acute lymphoblastic leukemia.
J Pediatr Hematol Oncol. 2003;25:484-487.
[PubMed: 12794528]
100. Walsh S, Phillips F. Deep vein thrombosis associated with
pediatric musculoskeletal sepsis. J Pediatr Orthop. 2002;22(3):329-332.
101. Crary SE, Buchanan GR, Drake CE, Journeycake JM. Venous
thrombosis and thromboembolism in children with osteomyelitis. J
Pediatr. 2006;49:537-541.
102. Monagle P. Thrombosis in pediatric cardiac patients. Semin
Thromb Hemost. 2003;29(6):547-555.
103. Freedom RM, Hamilton R, Yoo SJ, et al. The Fontan procedure:
analysis of cohorts and late complications. Cardiol Young. 2000;10(4):307-331.
104. Monagle P, Karl TR. Thromboembolic problems after the Fontan
operation.
Semin Thorac Cardiovasc Surg Pediatr Card Surg
Annu. 2002;5:36-47.
[PubMed: 11994863]
105. Kaulitz R, Ziemer G, Rauch R, et al. Prophylaxis of thromboembolic
complications after the Fontan operation (total cavopulmonary anastomosis). J
Thorac Cardiovasc Surg. 2005;129(3):569-575.
106. Jacobs ML, Pourmoghadam KK, Geary EM, et al. Fontan’s operation:
is aspirin enough? Is Coumadin too much? Ann Thorac Surg. 2002;73(1):64-68.
107. Durongpisitkul K, Gururaj VJ, Park JM, Martin CF. The prevention
of coronary artery aneurysm in Kawasaki disease: a meta-analysis
on the efficacy of aspirin and immunoglobulin treatment. Pediatrics. 1995;96(6):1057-1061.
108. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis,
treatment, and long-term management of Kawasaki disease: a statement
for health professionals from the Committee on Rheumatic Fever, Endocarditis,
and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American
Heart Association. Pediatrics. 2004;114(6):1708-1733.
109. Levine JS, Branch W, Rauch J. The antiphospholipid antibody
syndrome.
N Engl J Med. 2002;346:752-763.
[PubMed: 11882732]
110. Burk C, Miller L, Handler S, Cohen A. Preoperative history and
coagulation screening in children undergoing tonsillectomy.
Pediatrics.
1992;89:691-695.
[PubMed: 1557263]
111. Blickstein D, Blickstein I. Oral contraception and thrombophilia.
Curr
Opin Obstet Gynecol. 2007;19:370-376.
[PubMed: 17625421]
112. Makris M, Rosendaal FR, Preston FE. Familial thrombophilia:
genetic risk factors and management. J Intern Med. 1997;740(suppl):9-15.
113. M. Mannucci. Genetic hypercoagulability: prevention suggests
testing family members. Blood. 2001;98:21-22.
114. Green D. Genetic hypercoagulability: screening should be an
informed choice.
Blood. 2001; 98(1):20.
[PubMed: 11418456]
115. Bauer KA, Rosendaal FR, Heit JA. Hypercoagulability: too
many tests, too much conflicting data. Hematology (Am Soc
Hematol Educ Prog.) 2002:353-368.
116. Journeycake JM, Manco-Johnson MJ. Thrombosis during infancy
and childhood: what we know and what we do not know.
Hematol
Oncol Clin North Am. 2004;18:1315-1338, viii-ix.
[PubMed: 15511618]
117. Andrew M, Marzinotto V, Massicotte P, et al. Heparin therapy
in pediatric patients: a prospective cohort study.
Pediatr
Res. 1994; 35(1):78-83.
[PubMed: 8134203]
118. Vieira A, Berry L, Ofosu F, Andrew M. Heparin sensitivity and
resistance in the neonate: an explanation. Thromb Res. 1991;63(1):85-98.
119. Andrew M, Schmidt B. Use of heparin in newborn infants. Semin
Thromb Hemost. 1988;14(1): 28-32.
120. Klenner AF, Lubenow N, Raschke R, Greinacher A. Heparin-induced
thrombocytopenia in children: 12 new cases and review of the literature. Thromb
Haemost. 2004;91(4):719-724.
121. Wawrzynska L, Tomkowski WZ, Przedlacki J, Hajduk B, Torbicki
A. Changes in bone density during long-term administration of low-molecular-weight
heparins or acenocoumarol for secondary prophylaxis of venous thromboembolism. Pathophysiol
Haemost Thromb. 2003;33(2):64-67.
122. Crary SE, Van Orden H, Journeycake JM. Experience with
intravenous enoxaparin in critically ill infants and children.
Pediatr
Crit Care Med. 2008; 9:647-649.
[PubMed: 18838932]
123. Massicotte P, Julian JA, Marzinotto V, et al. Dose-finding
and pharmacokinetic profiles of prophylactic doses of a low molecular
weight heparin (reviparin-sodium) in pediatric patients. Thromb
Res. 2003;109(2-3):93-99.
124. Streif W, Andrew M, Marzinotto V, et al. Analysis of warfarin
therapy in pediatric patients: A prospective cohort study of 319
patients. Blood. 1999;94(9):3007-3014.
125. Young G, Yonekawa KE, Nakagawa P, Nugent DJ. Argatroban
as an alternative to heparin in extracorporeal membrane oxygenation
circuits. Perfusion. 2004;19(5):283-288.
126. Young G. Current and future antithrombotic agents in children. Expert
Rev Cardiovasc Ther. 2004;2(4):523-534.
127. Monagle P, Cochrane A, McCrindle B, Benson L, Williams
W, Andrew M. Thromboembolic complications after fontan procedures—the
role of prophylactic anticoagulation. J Thorac Cardiovasc
Surg. 1998;115(3):493-498.
128. Choi M, Massicotte MP, Marzinotto V, Chan AK, Holmes JL,
Andrew M. The use of alteplase to restore patency of central venous
lines in pediatric patients: a cohort study. J Pediatr. 2001;139(1):152-156.
129. Gupta AA, Leaker M, Andrew M, et al. Safety and outcomes
of thrombolysis with tissue plasminogen activator for treatment
of intravascular thrombosis in children. J Pediatr. 2001;139(5):
682-688.
130. Manco-Johnson MJ, Grabowski EF, Hellgreen M, et al. Recommendations
for tPA thrombolysis in children. On behalf of the Scientific Subcommittee
on Perinatal and Pediatric Thrombosis of the Scientific and Standardization Committee
of the International Society of Thrombosis and Haemostasis. Thromb
Haemost. 2002;88(1):157-158.
131. Wang M, Hays T, Balasa V, et al. Low-dose tissue plasminogen
activator thrombolysis in children. J Pediatr Hematol Oncol. 2003;25(5):379-386.
132. Chabrier S, Husson B, Lasjaunias P, Landrieu P, Tardieu M.
Stroke in childhood: outcome and recurrence risk by mechanism in
59 patients.
J Child Neurol. 2000;15:290-294.
[PubMed: 10830194]
133. Strater R, Becker S, von Eckardsteini A, et al. Prospective assessment
of risk factors for recurrent stroke during childhood–a
5-year follow-up study.
Lancet. 2002;360:1540-1545.
[PubMed: 12443591]
134. Steinlin M, Roellin K, Schroth G. Long-term follow-up after
stroke in childhood.
Eur J Pediatr. 2004;163:245-250.
[PubMed: 14986120]
135. Hogan AM, Kirkham FJ, Isaacs EB. Intelligence after stroke
in childhood: review of the literature and suggestions for future
research.
J Child Neurol. 2000;15:325-332.
[PubMed: 10830199]
136. Prandoni P, Frulla M, Sartor D, Concolato A, Girolami A. Vein
abnormalities and the post-thrombotic syndrome. J Thromb
Haemost. 2005;3(2):401-402.
137. Kahn SR, Ginsberg JS. The post-thrombotic syndrome: current
knowledge, controversies, and directions for future research. Blood
Rev. 2002;16(3):155-165.
138. Forster AJ, Wells PS. The rationale and evidence for the treatment
of lower-extremity deep venous thrombosis with thrombolytic agents. Curr
Opin Hematol. 2002;9(5):437-442.
139. Kuhle S, Koloshuk B, Marzinotto V, et al. A cross-sectional
study evaluating post-thrombotic syndrome in children. Thromb
Res. 2003;111(4-5):227-233.
140. Journeycake JM, Eshelman DA, Buchanan GR. Post-thrombotic
syndrome following central venous catheter use in childhood cancer
survivors. J Pediatr. 2006;275-277.
141. Ziegler S, Schillinger M, Maca TH, Minar E. Post-thrombotic
syndrome after primary event of deep venous thrombosis 10 to 20
years ago. Thromb Res. 2001;101(2):23-33.